The Intellectual Property Appellate Board (IPAB), which hears appeals against the decisions of the IPO, has been dysfunctional owing to lack of appointment of chairperson. In a related petition filed by Novartis AG, an ordered was passed seeking information regarding the total number of pending cases, and appointment of chairperson and technical members of IPAB. Further on, in a matter that has implications on the functioning of the IPAB, the Supreme Court struck down Tribunal, Appellate Tribunal and other Authorities Rules, 2017, and currently the Trademarks Act will govern the appointments to the IPAB till new rules are framed. With these developments, we hope the IPAB will be functional soon. Download Novartis Order and Supreme Court Judgement